Recognizing women in medicine committed to empowering breast cancer patients to make personalized treatment decisions
Dr. Erica Giblin
Dr. Erica Giblin
“I send every qualified patient I see with ductal carcinoma in situ (#DCIS) for the #DCISionRT test, even the ones with a tiny low-grade lesion, because sometimes the test reveals an elevated risk recurrence score, which is surprising. And I never want to miss offering radiation modality options to patients who will benefit. I have seen the greatest decision impact on those women who were not inclined to undergo radiation but when their DCISion score is high, they choose to proceed with radiation.” To read more about Dr. Dube’s story visit her blog post here.
Dr. Niti Dube
“I send every qualified patient I see with ductal carcinoma in situ (#DCIS) for the #DCISionRT test, even the ones with a tiny low-grade lesion, because sometimes the test reveals an elevated risk recurrence score, which is surprising. And I never want to miss offering radiation modality options to patients who will benefit. I have seen the greatest decision impact on those women who were not inclined to undergo radiation but when their DCISion score is high, they choose to proceed with radiation.” To read more about Dr. Dube’s story visit her blog post here.
As a radiation oncologist, one of the primary benefits of DCISionRT is that I now can see and treat women with DCIS who may not have normally been referred to me, so we are actually seeing more DCIS patients. Using traditional pathology, some women are deemed low risk of recurrence and not referred for an opinion regarding radiotherapy. This decision was often made by the surgeon or the multidisciplinary team. The use of DCISionRT has been enlightening for the whole care team, revealing that some women who are diagnosed as low risk via traditional clinicopathology are actually elevated risk.” To read more about Dr. Zissiadis’s story visit her blog post here.
Dr. Yvonne Zissiadis
As a radiation oncologist, one of the primary benefits of DCISionRT is that I now can see and treat women with DCIS who may not have normally been referred to me, so we are actually seeing more DCIS patients. Using traditional pathology, some women are deemed low risk of recurrence and not referred for an opinion regarding radiotherapy. This decision was often made by the surgeon or the multidisciplinary team. The use of DCISionRT has been enlightening for the whole care team, revealing that some women who are diagnosed as low risk via traditional clinicopathology are actually elevated risk.” To read more about Dr. Zissiadis’s story visit her blog post here.
“In practice, I think there is a fine line between overtreating and undertreating breast cancer patients, and DCIS is squarely in that gray zone. Prior to DCISionRT, all DCIS patients got radiation. As an academic institution, we value and pride ourselves on following evidence-based literature and recommendations. DCISionRT is backed by strong evidence. That makes it easy to incorporate. And it is an important tool to use as a multidisciplinary group to determine if we should recommend radiation or not, because we are finding out that some women don’t actually need radiation.” To read more about Dr. Valente’s story visit her blog post here.
Dr. Stephanie Valente
“In practice, I think there is a fine line between overtreating and undertreating breast cancer patients, and DCIS is squarely in that gray zone. Prior to DCISionRT, all DCIS patients got radiation. As an academic institution, we value and pride ourselves on following evidence-based literature and recommendations. DCISionRT is backed by strong evidence. That makes it easy to incorporate. And it is an important tool to use as a multidisciplinary group to determine if we should recommend radiation or not, because we are finding out that some women don’t actually need radiation.” To read more about Dr. Valente’s story visit her blog post here.
Dr. Lindsay Keith
Dr. Lindsay Keith is a strong proponent of leveraging the latest technologies in guiding ductal carcinoma in situ (DCIS) treatment decisions and empowering her patients. “The most gratifying part of my job is taking care of breast cancer patients. They have a fight in them. They want to get better, and they deserve a personalized diagnosis and treatment plan. The DCISionRT test gives us more information so that we can make more informed decisions whether it is helping a patient decide to move forward with radiation following breast conserving surgery or guiding in surgical planning.” To read more about Dr. Keith’s story visit https://bit.ly/3lrBDLW
Dr. Lindsay Keith
Dr. Lindsay Keith is a strong proponent of leveraging the latest technologies in guiding ductal carcinoma in situ (DCIS) treatment decisions and empowering her patients. “The most gratifying part of my job is taking care of breast cancer patients. They have a fight in them. They want to get better, and they deserve a personalized diagnosis and treatment plan. The DCISionRT test gives us more information so that we can make more informed decisions whether it is helping a patient decide to move forward with radiation following breast conserving surgery or guiding in surgical planning.” To read more about Dr. Keith’s story visit https://bit.ly/3lrBDLW
Nicole L. Sroka, MD
Dr. Janie Grumley
Dr. Janie Grumley, MD, FACS
Dr. Arica Hirsch
Dr. Arica Hirsch
Dr. Karen Barbosa
TidalHealth Delaware Breast Cancer Program
Millsboro, DE
Dr. Karen Barbosa is a strong proponent of leveraging genomic testing early in the process to arm the patient with as much information as possible.
“In cancer care, I think that it is really important for women to understand the difference between invasive cancer and ductal carcinoma in situ (DCIS) and their treatment options. And to ensure appropriate treatment of DCIS, I will typically order DCISionRT on the core biopsy sample of DCIS. That way the patient is empowered heading into surgery and can feel more confident during their radiation oncology consultation and in their ultimate treatment decision.”
To read more about Dr. Barbosa’s story visit https://bit.ly/3B1ECQj
Dr. Karen Barbosa
Dr. Karen Barbosa is a strong proponent of leveraging genomic testing early in the process to arm the patient with as much information as possible.
“In cancer care, I think that it is really important for women to understand the difference between invasive cancer and ductal carcinoma in situ (DCIS) and their treatment options. And to ensure appropriate treatment of DCIS, I will typically order DCISionRT on the core biopsy sample of DCIS. That way the patient is empowered heading into surgery and can feel more confident during their radiation oncology consultation and in their ultimate treatment decision.”
To read more about Dr. Barbosa’s story visit https://bit.ly/3B1ECQj
Regardless of which path a breast cancer warrior decides to take following diagnosis, they’re unlikely to get out without at least a few less-than-comfortable procedures. After years of watching her patients struggle with uncomfortable garments following lumpectomies and mastectomies, Dr. Lea Blackwell— a breast surgery fellowship trained surgeon out of Fort Myers, Florida— decided to take matters into her own hands and created the Blackwell Bra, a post-operative surgical bra.
“Every breast cancer patient deserves the best possible tools at our disposal before, during and after surgery,” she says.
Offering the Blackwell Bra to patients is a continuation of her dedication to their best interests that starts before she ever picks up a scalpel. To read about how Dr. Blackwell and others utilize DCISionRT genomic testing in their practices, please visit https://bit.ly/3k9X4RK.
Dr. Lea Blackwell
“Every breast cancer patient deserves the best possible tools at our disposal before, during and after surgery,” she says.
Offering the Blackwell Bra to patients is a continuation of her dedication to their best interests that starts before she ever picks up a scalpel. To read about how Dr. Blackwell and others utilize DCISionRT genomic testing in their practices, please visit https://bit.ly/3k9X4RK.
Dr. Beth DuPree
General Surgeon specializing in breast and Integrative Medicine
The Cancer Centers of Northern Arizona Healthcare
Sedona, AZ
Did you know that a 2008 study by the U.S. Department of Health found that 38% of adult Americans sought out Integrative Medicine for healthcare, yet only around 1,000 physicians in the U.S. are licensed by the American Board of Integrative Medicine? Northern Arizona Healthcare’s Dr. Beth DuPree is not only part of that 0.1%, but a trailblazer within it.
Throughout her over 30 year career as a general surgeon, Dr. DuPree has dedicated herself to pushing the boundaries of patient care while recognizing and eagerly implanting game-changing technology. From holistic practices to cutting-edge surgical techniques to genomic tests such as DCISionRT, she is a fierce advocate for her patients. Not only does she talk the talk through her best-selling book, The Healing Consciousness: A Doctor’s Journey to Healing, but she walks the walk through its namesake foundation, through which she offers resources and education to patients free of charge.
To learn more about why Dr. DuPree feels that genomic data is crucial to offering her patients their best care plan, visit our blog at https://bit.ly/3suwYvd
Dr. Beth DuPree
Did you know that a 2008 study by the U.S. Department of Health found that 38% of adult Americans sought out Integrative Medicine for healthcare, yet only around 1,000 physicians in the U.S. are licensed by the American Board of Integrative Medicine? Northern Arizona Healthcare’s Dr. Beth DuPree is not only part of that 0.1%, but a trailblazer within it.
Throughout her over 30 year career as a general surgeon, Dr. DuPree has dedicated herself to pushing the boundaries of patient care while recognizing and eagerly implanting game-changing technology. From holistic practices to cutting-edge surgical techniques to genomic tests such as DCISionRT, she is a fierce advocate for her patients. Not only does she talk the talk through her best-selling book, The Healing Consciousness: A Doctor’s Journey to Healing, but she walks the walk through its namesake foundation, through which she offers resources and education to patients free of charge.
To learn more about why Dr. DuPree feels that genomic data is crucial to offering her patients their best care plan, visit our blog at https://bit.ly/3suwYvd
Dr. Linsey Gold
Fellowship-trained Breast Surgeon
Comprehensive Breast Care
Troy, MI
Voted one of Metro Detroit’s “Top Docs” two years running, Dr. Linsey Gold of Comprehensive Breast Care feels strongly about treating every patient as she would treat her own family. A huge part of that means relying on precision medicine for treating DCIS breast cancer in addition to traditional clinical pathology.
“It’s no surprise to me whatsoever that the recent data says 42% of the time, there’s a change in treatment recommendation after DCISionRT because that’s exactly what it feels like,” she says.
Dr. Linsey Gold
Voted one of Metro Detroit’s “Top Docs” two years running, Dr. Linsey Gold of Comprehensive Breast Care feels strongly about treating every patient as she would treat her own family. A huge part of that means relying on precision medicine for treating DCIS breast cancer in addition to traditional clinical pathology.
“It’s no surprise to me whatsoever that the recent data says 42% of the time, there’s a change in treatment recommendation after DCISionRT because that’s exactly what it feels like,” she says.
Dr. Nathalie Johnson
Legacy Health’s Dr. Nathalie Johnson was just a few years out from publishing her children’s book, “Mommy Found a Lump”, to help her breast cancer patients explain the concept to their kids when she had to reach for the book herself. And even an extensive career as a decorated surgical oncologist specializing in breast cancer cannot fully prepare you to hear your physician say that you, too, have been diagnosed with it.
“If you can find and address breast cancer early,” she says, “I’m living proof that the best is yet to come.”
As the medical director for both Legacy’s Cancer Institute and Breast Health Centers, Dr. Johnson puts her training, her surgical skills, and her heart into serving each one of her patients with warmth and excellence. At PreludeDx, we are proud to recognize her work as a Woman Treating Women with DCIS breast cancer. To learn more about how and why Dr. Johnson and others reach for DCISionRT when approaching treatment decisions with their patients, please visit: https://preludedx.com/
Dr. Natalie Johnson
Legacy Health’s Dr. Nathalie Johnson was just a few years out from publishing her children’s book, “Mommy Found a Lump”, to help her breast cancer patients explain the concept to their kids when she had to reach for the book herself. And even an extensive career as a decorated surgical oncologist specializing in breast cancer cannot fully prepare you to hear your physician say that you, too, have been diagnosed with it.
“If you can find and address breast cancer early,” she says, “I’m living proof that the best is yet to come.”
As the medical director for both Legacy’s Cancer Institute and Breast Health Centers, Dr. Johnson puts her training, her surgical skills, and her heart into serving each one of her patients with warmth and excellence. At PreludeDx, we are proud to recognize her work as a Woman Treating Women with DCIS breast cancer. To learn more about how and why Dr. Johnson and others reach for DCISionRT when approaching treatment decisions with their patients, please visit: https://preludedx.com/
Dr. Kristina Mirabeau-Beale
Radiation Oncology Specialist
GenesisCare
Ft. Myers, FL
Dr. Kristina Mirabeau-Beale
Dr. Stella Hetelekidis
Radiation Oncologist
Radiation Oncology Associates
Fairfax,VA
Treating DCIS breast cancer is far from a one-person job. The patient joins forces with radiation oncologists, surgeons, medical oncologists, nurses, and other medical team members to encourage the best possible outcome.
PreludeDx is proud to continue celebrating the many Women Treating Women™, such as radiation oncologist Dr. Stella Hetelekidis of the Inova Schar Cancer Institute, collaborating to beat DCIS breast cancer with precision medicine.
“It’s important to me to develop a deep relationship with my patients because ultimately, along with many other physicians, we’re a team,” says Dr. Hetelekidis. “And the patient is of course a leading part of that team.”
For more information on how Dr. Hetelekidis and many more team up with PreludeDx’s DCISionRT to treat women with DCIS breast cancer, please visit https://preludedx.com/physicians
Dr. Stella Hetelekidis
Treating DCIS breast cancer is far from a one-person job. The patient joins forces with radiation oncologists, surgeons, medical oncologists, nurses, and other medical team members to encourage the best possible outcome.
PreludeDx is proud to continue celebrating the many Women Treating Women™, such as radiation oncologist Dr. Stella Hetelekidis of the Inova Schar Cancer Institute, collaborating to beat DCIS breast cancer with precision medicine.
“It’s important to me to develop a deep relationship with my patients because ultimately, along with many other physicians, we’re a team,” says Dr. Hetelekidis. “And the patient is of course a leading part of that team.”
For more information on how Dr. Hetelekidis and many more team up with PreludeDx’s DCISionRT to treat women with DCIS breast cancer, please visit https://preludedx.com/physicians
Dr. Sheree Brown
Radiation Oncologist
Wellstar Medical Group
Marietta, GA
For Black History month, PreludeDx is honored to recognize and celebrate the achievements of Black doctors, and particularly Women Treating Women with DCIS breast cancer. We are honored to recognize radiation oncologist Dr. Sheree Brown and her impactful contributions and commitment to treating breast cancer.
“My passion lies in building relationships with my patients and making a difference in each of their lives,” she says. “I truly enjoy helping people and caring for my patients.”
Visit https://preludedx.com/physicians/ to learn how Dr. Sheree Brown and many others help women with DCIS by utilizing DCISionRT to provide personalized and informed treatment.
Dr. Sheree Brown
For Black History month, PreludeDx is honored to recognize and celebrate the achievements of Black doctors, and particularly Women Treating Women with DCIS breast cancer. We are honored to recognize radiation oncologist Dr. Sheree Brown and her impactful contributions and commitment to treating breast cancer.
“My passion lies in building relationships with my patients and making a difference in each of their lives,” she says. “I truly enjoy helping people and caring for my patients.”
Visit https://preludedx.com/physicians/ to learn how Dr. Sheree Brown and many others help women with DCIS by utilizing DCISionRT to provide personalized and informed treatment.
Dr. Rachel Rabinovitch
Radiation Oncologist
UCHealth Radiation Oncology – Anschutz Medical Campus
Aurora, CO
In 2021, we are proud to continue showing appreciation for Women Treating Women™. Of the ~60,000 women expected to be diagnosed with DCIS in the new year, those treated by physicians like Dr. Rachel Rabinovitch, radiation oncologist at UCHealth (University of Colorado), will fight the battle armed with the security of knowing her treatment plan has been well informed according to her tumor biology. “Cancer care can be very complicated, and it is important to me that my patients are informed and educated partners in whatever treatment they chose to receive,” she says.
For more information on how Dr. Rabinovitch and others do just that by utilizing DCISionRT to determine if radiation will benefit a specific woman with DCIS breast cancer, please visit: https://preludedx.com/physicians
Dr. Rachel Rabinovitch
For more information on how Dr. Rabinovitch and others do just that by utilizing DCISionRT to determine if radiation will benefit a specific woman with DCIS breast cancer, please visit: https://preludedx.com/physicians
Dr. April Spencer
Founder and Chief Operating Surgeon of Dr. Spencer’s Global Breast Health & Wellness Center
Conyers, GA
Did you know that there are only 60 hospitals in the US with breast oncology Fellowship programs? Fellowship trained breast surgeons spend an additional year of comprehensive training after already completing 5 years of general surgery training according to Society of Surgical Oncology. Breast oncology Fellowships promote comprehensive breast cancer treatment plans using a multidisciplinary, patient-centered approach.
Meet Fellowship trained breast surgeon, Dr. April Spencer, and learn how she utilizes her patient-centered approach and expertise to formulate the best treatment plan for each unique patient. https://
“I provide comprehensive, 100% dedicated breast surgery practice with dignity and detail in a serene, patient-centered environment. Together we can treat it, beat it, move on!”
Visit https://preludedx.com/
Dr. April Spencer
Did you know that there are only 60 hospitals in the US with breast oncology Fellowship programs? Fellowship trained breast surgeons spend an additional year of comprehensive training after already completing 5 years of general surgery training according to Society of Surgical Oncology. Breast oncology Fellowships promote comprehensive breast cancer treatment plans using a multidisciplinary, patient-centered approach.
Meet Fellowship trained breast surgeon, Dr. April Spencer, and learn how she utilizes her patient-centered approach and expertise to formulate the best treatment plan for each unique patient. https://
“I provide comprehensive, 100% dedicated breast surgery practice with dignity and detail in a serene, patient-centered environment. Together we can treat it, beat it, move on!”
Visit https://preludedx.com/
Dr. Anne Peled
Dual Fellowship Trained Oncologic Breast Surgeon and Board Certified Plastic Reconstructive Surgeon
San Fransisco, CA
Dr. Anne Peled
Dr. Catherine Hwang
Section Chief of Breast Radiation Oncology
AdventHealth Cancer Institute
Orlando, FL
Approximately 60,000 women are diagnosed with DCIS (Stage0) breast cancer each year according to @breastcancer.org, and DCISionRT testing can help these women and their doctors make informed and personalized DCIS treatment decisions.
In this last week of Breast Cancer Awareness month, we’d like to continue recognizing Women Treating Women with DCIS. Meet Section Chief of Breast Radiation Oncology, Dr. Catherine Hwang, who recognizes and values the uniqueness of each of her patients.
“Even though breast cancer is a common diagnosis among women, each case is different and each patient has her own story and concerns. By integrating compassionate care with the most recent advances in breast cancer, I am able to provide my patients with the best possible treatment options.”
Learn how Dr. Catherine Hwang and others use a personalized approach to determine if radiation will benefit a specific woman with DCIS breast cancer. Visit Physicians for more information.
Dr. Catherine Hwang
Approximately 60,000 women are diagnosed with DCIS (Stage0) breast cancer each year according to @breastcancer.org, and DCISionRT testing can help these women and their doctors make informed and personalized DCIS treatment decisions.
In this last week of Breast Cancer Awareness month, we’d like to continue recognizing Women Treating Women with DCIS. Meet Section Chief of Breast Radiation Oncology, Dr. Catherine Hwang, who recognizes and values the uniqueness of each of her patients.
“Even though breast cancer is a common diagnosis among women, each case is different and each patient has her own story and concerns. By integrating compassionate care with the most recent advances in breast cancer, I am able to provide my patients with the best possible treatment options.”
Learn how Dr. Catherine Hwang and others use a personalized approach to determine if radiation will benefit a specific woman with DCIS breast cancer. Visit Physicians for more information.
Dr. Anushka Patel
Radiation Oncologist
Arizona Center for Cancer Care
Phoenix and Scottsdale, AZ
We are honored to recognize Women Treating Women™ diagnosed with DCIS Breast Cancer.
Meet radiation oncologist, Dr. Anushka Patel, and learn how she helps her patients with breast cancer thrive through patient-centered treatment.
“I have had the privilege of practicing radiation oncology for 11 years and have developed a particular interest in providing patient-centered treatment of breast cancer. My passion goes beyond treatment and focuses on building personal relationships with my patients. This allows me to offer highly individualized care. I believe the process of understanding my patient’s needs, taking time to educate them of their best options, and providing support throughout treatment, helps my breast cancer patients not only survive but thrive.”
Learn how Dr. Anushka Patel and others use a personalized approach to determine if radiation will benefit women with DCIS breast cancer. Visit Physicians for more information.
Dr. Anushka Patel
We are honored to recognize Women Treating Women™ diagnosed with DCIS Breast Cancer.
Meet radiation oncologist, Dr. Anushka Patel, and learn how she helps her patients with breast cancer thrive through patient-centered treatment.
“I have had the privilege of practicing radiation oncology for 11 years and have developed a particular interest in providing patient-centered treatment of breast cancer. My passion goes beyond treatment and focuses on building personal relationships with my patients. This allows me to offer highly individualized care. I believe the process of understanding my patient’s needs, taking time to educate them of their best options, and providing support throughout treatment, helps my breast cancer patients not only survive but thrive.”
Learn how Dr. Anushka Patel and others use a personalized approach to determine if radiation will benefit women with DCIS breast cancer. Visit Physicians for more information.
Dr. Christy Kesslering
Radiation Oncology Consultants
Warrenville, IL
During Breast Cancer Awareness Month, PreludeDx is celebrating Women Treating Women™ with Breast Cancer.
Learn how Dr. Christy Kesslering and other breast cancer doctors use a personalized approach to determine if Radiation Therapy will benefit women with DCIS breast cancer. Visit Physicians for more information.
Read our newest blog post featuring Dr. Christy Kesslering
Dr. Christy Kesslering
During Breast Cancer Awareness Month, PreludeDx is celebrating Women Treating Women™ with Breast Cancer.
Learn how Dr. Christy Kesslering and other breast cancer doctors use a personalized approach to determine if Radiation Therapy will benefit women with DCIS breast cancer. Visit Physicians for more information.
Read our newest blog post featuring Dr. Christy Kesslering